ATE71535T1 - Pharmazeutische zubereitungen. - Google Patents

Pharmazeutische zubereitungen.

Info

Publication number
ATE71535T1
ATE71535T1 AT87310551T AT87310551T ATE71535T1 AT E71535 T1 ATE71535 T1 AT E71535T1 AT 87310551 T AT87310551 T AT 87310551T AT 87310551 T AT87310551 T AT 87310551T AT E71535 T1 ATE71535 T1 AT E71535T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
antihypertensive agent
hypertension
therapy
simultaneous
Prior art date
Application number
AT87310551T
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629234A external-priority patent/GB8629234D0/en
Priority claimed from GB868630926A external-priority patent/GB8630926D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE71535T1 publication Critical patent/ATE71535T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87310551T 1986-12-06 1987-11-30 Pharmazeutische zubereitungen. ATE71535T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868629234A GB8629234D0 (en) 1986-12-06 1986-12-06 Pharmaceutical preparations
GB868630926A GB8630926D0 (en) 1986-12-24 1986-12-24 Pharmaceutical preparations
EP87310551A EP0271271B1 (de) 1986-12-06 1987-11-30 Pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ATE71535T1 true ATE71535T1 (de) 1992-02-15

Family

ID=26291661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87310551T ATE71535T1 (de) 1986-12-06 1987-11-30 Pharmazeutische zubereitungen.

Country Status (11)

Country Link
EP (1) EP0271271B1 (de)
KR (1) KR880007081A (de)
AT (1) ATE71535T1 (de)
AU (1) AU607728B2 (de)
CA (1) CA1305420C (de)
DE (1) DE3776111D1 (de)
DK (1) DK639887A (de)
ES (1) ES2055709T3 (de)
GR (1) GR3003599T3 (de)
NZ (1) NZ222806A (de)
PT (1) PT86292B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
GB8915315D0 (en) * 1989-07-04 1989-08-23 Sandoz Ltd Pharmaceutical compositions for use against hypertension and congestive heart failure
EP0555681A1 (de) * 1992-02-13 1993-08-18 E.R. SQUIBB & SONS, INC. Verwendung einer Kombination von Kalium-Kanal-Aktivatoren und Sulfhydryl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Ischämie und des Myokardiefarkts
DE69327965T2 (de) * 1992-12-11 2000-10-19 Smithkline Beecham Corp., Philadelphia Pharmazeutische zusammenstellung enthaltende bizyklisch typ verbindungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
EP0271271B1 (de) 1992-01-15
CA1305420C (en) 1992-07-21
DE3776111D1 (de) 1992-02-27
EP0271271A3 (en) 1989-11-15
EP0271271A2 (de) 1988-06-15
DK639887A (da) 1988-06-07
PT86292B (pt) 1990-11-07
DK639887D0 (da) 1987-12-04
PT86292A (pt) 1988-01-01
GR3003599T3 (de) 1993-03-16
KR880007081A (ko) 1988-08-26
NZ222806A (en) 1991-05-28
ES2055709T3 (es) 1994-09-01
AU607728B2 (en) 1991-03-14
AU8209987A (en) 1988-06-09

Similar Documents

Publication Publication Date Title
DK2689D0 (da) Farmaceutisk praeparat
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DE69940674D1 (de) Orale verabreichung von adenosin analogen
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
EP0211592A3 (de) Pharmazeutische Einzeldosis
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE3776111D1 (de) Pharmazeutische zubereitungen.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
AU580890B2 (en) P-acylaminobenzamides
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
FI874823A0 (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
DK163175C (da) Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol
ATE102031T1 (de) Pharmazeutische zubereitung.
DE69011692D1 (de) Therapeutische mittel.
BR1100888A (pt) Variantes de ativador de plasminogênios de tecido, composições e métodos de uso da mesma
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee